Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
The retinoblastoma (Rb) tumor suppressor controls cellular proliferation, survival, and differentiation and is functionally inactivated by mutations or hyperphosphorylation in most human cancers. Although activation of endogenous Rb is thought to provide an effective approach to suppress cell proliferation, long-term inhibition of apoptosis by active Rb may have detrimental consequences in vivo. To directly test these paradigms, we targeted phosphorylation-resistant constitutively active Rb alleles, RbΔKs, to the mouse mammary gland. Pubescent transgenic females displayed reduced ductal elongation and cell proliferation at the endbuds. Postpuberty transgenic mice exhibited precocious cellular differentiation and β-casein expression and extended survival of the mammary epithelium with a moderate but specific effect on the expression of E2F1, IGF1Rα, and phospho–protein kinase B/AKT. Remarkably, ∼30% RbΔK transgenic females developed focal hyperplastic nodules, and ∼7% exhibited full-blown mammary adenocarcinomas within 15 mo. Expression of the RbΔK transgene in these mammary tumors was reduced greatly. Our results suggest that transient activation of Rb induces cancer by extending cell survival and that the dual effects of Rb on cell proliferation and apoptosis impose an inherent caveat to the use of the Rb pathway for long-term cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The idea that RB could promote cancer under certain conditions by increasing survival is supported by experiments in transgenic mice expressing a phosphorylation-resistant, constitutively active allele of Rb in the mammary gland epithelium.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [86]
In the citing paper
“Strikingly, these transgenic mice develop focal hyperplastic lesions and mammary tumours, probably because the survival of differentiated mammary epithelial cells is extended after pregnancy86.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724 · cited 1×
“However, as stated recently (Evan and Vousden, 2001) many growth deregulatory mutations have pleiotropic and tissue-specific effects on cell proliferation and apoptosis, and the therapeutic consequences of antiproliferative agents are thus difficult to predict.”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 3×
“…Rb in cell proliferation and apoptosis is well established, it is not clear whether Rb affects terminal differentiation directly through interaction with differentiation factors or indirectly by allowing proper cell cycle exit and cell survival (Dyson, 1998; Macleod, 1999; Harbour and Dean, 2000b).”
BackgroundInfluentialThe Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,408
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213 · cited 1×
“Similarly, a BCl2 transgene induces hyperplastic splenic follicles, which do not progress to B cell lymphoma in transgenic mice (McDonnell et al., 1989).”
BackgroundThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 3×
“Mechanisms of precocious differentiation in MMTV-Rb K transgenic mice Although the role of Rb in cell proliferation and apoptosis is well established, it is not clear whether Rb affects terminal differentiation directly through interaction with differentiation factors or indirectly by allowing proper cell cycle exit a…”
BackgroundLundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067 · cited 4×
“Mitotic signals propagated through G1 cyclins induce sequential phosphorylation and inactivation of Rb (Lundberg and Weinberg, 1998).”
BackgroundInfluentialHarbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057 · cited 5×
“…to their resistance to phosphorylation by Cdks, the Rb Ks outperform wild-type Rb in multiple assays and are viewed as constitutively active, underphosphorylated, native Rb (Hamel et al., 1992; Geng et al., 1996; Knudsen et al., 1998; Sellers et al., 1998; Brown et al., 1999; Harbour et al., 1999).”
BackgroundInfluentialCyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · cited 2×
“In contrast to the MMTV/WAP-Rb K transgenic mice, cyclin D1–deficient mice do not succumb to mammary tumors but are rather protected from a subset of oncogenic pathways in the mammary gland (Sicinski et al., 1995; Yu et al., 2001b).”
BackgroundResultFunctional domains of the human glucocorticoid receptor
Giguère, V., Hollenberg, S. M., Rosenfeld, M. G., & Evans, R. M. (1986) · Cell · doi:10.1016/0092-8674(86)90339-9 · Cited by 918 · cited 2×
“To induce the MMTV-LTR promoter, COS cells were transfected with pBSMMTV-HA-Rb p34 or pBS-MMTV-HA-Rb K11 together with an expression plasmid for the glucocorticoid receptor (Giguere et al., 1986; Zacksenhaus et al., 1996a), and the cells were cultured in the presence of dexamethasone for 36 h before analysis.”
MethodE2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., & Greenberg, M. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81255-6 · Cited by 754 · cited 3×
“Of relevance here is the observation that both overexpression and inactivation of E2F1 induce cancer in mouse models presumably by disrupting different aspects (proliferation versus apoptosis, respectively) of cell physiology (Field et al., 1996; Yamasaki et al., 1996; Pan et al., 1998; Pierce et al., 1998, 1999).”
BackgroundGu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., & Nadal-Ginard, B. (1993) · Cell · doi:10.1016/0092-8674(93)90110-c · Cited by 729 · cited 4×
“Alternatively, Rb may be required for the onset of terminal differentiation via direct or indirect stimulation of differentiation factors (e.g., glucocorticoid receptor, C/EBP, MyoD, etc.).”
BackgroundMethodInfluentialCDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720 · cited 1×
“For example, cyclin D1 binds and stimulates the estrogen receptor by acting as a bridging factor between the ER and steroid receptor coactivators (Neuman et al., 1997; Zwijsen et al., 1997, 1998).”
BackgroundRole for the p53 homologue p73 in E2F-1-induced apoptosis
Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., et al. (2000) · Nature · doi:10.1038/35036614 · Cited by 710 · cited 1×
“Moreover, in response to DNA damage ATM phosphorylates and stabilizes E2F1, thereby inducing apoptosis through p53 and p73 (Irwin et al., 2000; Lin et al., 2001).”
BackgroundTumor Induction and Tissue Atrophy in Mice Lacking E2F-1
Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., & Dyson, N. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81254-4 · Cited by 698 · cited 3×
“Of relevance here is the observation that both overexpression and inactivation of E2F1 induce cancer in mouse models presumably by disrupting different aspects (proliferation versus apoptosis, respectively) of cell physiology (Field et al., 1996; Yamasaki et al., 1996; Pan et al., 1998; Pierce et al., 1998, 1999).”
BackgroundFunctional interactions between Stat5 and the glucocorticoid receptor
Stöcklin, E., Wissler, M., Gouilleux, F., & Groner, B. (1996) · Nature · doi:10.1038/383726a0 · Cited by 675 · cited 2×
“, 1995), the glucocorticoid receptor (Stocklin et al., 1996), and other factors.”
BackgroundExpression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
Morgenbesser, S. D., Williams, B. O., Jacks, T., & DePinho, R. A. (1994) · Nature · doi:10.1038/371072a0 · Cited by 610 · cited 1×
“Consistent with these in vitro studies, apoptosis in Rb-deficient mice is mediated in certain tissues by an E2F1–p53-Apaf-1–dependent pathway (Morgenbesser et al., 1994; Macleod et al., 1996; Tsai et al., 1998; Guo et al., 2001).”
BackgroundApaf-1 is a transcriptional target for E2F and p53
Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K. (2001) · Nature Cell Biology · doi:10.1038/35078527 · Cited by 593 · cited 2×
“For example, deregulated E2F1 can induce the transcription of apoptosis protease-activating factor (Apaf)-1 (Moroni et al., 2001) and p14/19ARF, which binds and inactivates MDM2, a p53 inhibitor, thereby linking loss of Rb to p53-induced apoptosis (Sherr, 2000).”
BackgroundInfluentialSelective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.
Lin, W.-C., Lin, F., & Nevins, J. R. (2001) · PubMed Central · Cited by 553
Lund, L. R., Rømer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Danø, K., & Werb, Z. (1996) · Development · doi:10.1242/dev.122.1.181 · Cited by 546
Apoptotic cell death and tissue remodelling during mouse mammary gland involution
Strange, R., Li, F., Saurer, S., Burkhardt, A., & Friis, R. R. (1992) · Development · doi:10.1242/dev.115.1.49 · Cited by 534
Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203277 · Cited by 489 · cited 2×
“MMTV-Rb K transgenes suppress ductal growth in pubescent females During the ductal stage, the mammary epithelium infiltrates the fat pad by proliferation at the terminal endbuds (TEBs) and dichotomous side branching (Medina, 1996; Hennighausen and Robinson, 1998; Cardiff et al., 2000; Silberstein, 2001).”
BackgroundChang, M. W., Barr, E., Seltzer, J., Jiang, Y.-Q., Nabel, G. J., Nabel, E. G., Parmacek, M. S., & Leiden, J. M. (1995) · Science · doi:10.1126/science.7824950 · Cited by 446 · cited 3×
“In support of this notion, introduction of phosphorylation-resistant constitutively active Rb alleles, Rb Ks, into many cell types in vitro (Mittnacht, 1998) and in vivo (Chang et al., 1995) efficiently suppresses cell proliferation.”
BackgroundMethodInfluentialSiegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442 · cited 2×
“We note that numerous other MMTV transgenic mice expressing dominant-active alleles have been created, for example, neu/erbB2 (Siegel et al., 1999), -catenin (Imbert et al.”
BackgroundDevelopment of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice
Matsui, Y., Halter, S. A., Holt, J. T., Hogan, B. L. M., & Coffey, R. J. (1990) · Cell · doi:10.1016/0092-8674(90)90077-r · Cited by 440 · cited 3×
“684-kb XhoI fragment containing the MMTV-LTR and rabbit -globin cassette was transferred from mmtv-KCR plasmid (Matsui et al., 1990) provided by Dr.”
MethodInfluentialSympson, C. J. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.125.3.681 · Cited by 400 · cited 4×
“, 2001), stromolysin (Sympson et al., 1994), dominant negative TGF R (Gorska et al.”
BackgroundInfluentialCyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 392 · cited 1×
“For example, cyclin D1 binds and stimulates the estrogen receptor by acting as a bridging factor between the ER and steroid receptor coactivators (Neuman et al., 1997; Zwijsen et al., 1997, 1998).”
BackgroundControl of pRB phosphorylation
Mittnacht, S. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80057-9 · Cited by 389 · cited 4×
“In support of this notion, introduction of phosphorylation-resistant constitutively active Rb alleles, Rb Ks, into many cell types in vitro (Mittnacht, 1998) and in vivo (Chang et al., 1995) efficiently suppresses cell proliferation.”
BackgroundInfluentialCyclin D1 is an essential mediator of apoptotic neuronal cell death.
Kranenburg, O., van der Eb, A. J., & Zantema, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00332.x · Cited by 379 · cited 2×
“Furthermore, in vitro, loss of Rb increases cell susceptibility to cytotoxic drugs, whereas ectopic expression of Rb inhibits cell death (Almasan et al., 1995; Haas-Kogan et al., 1995; Kranenburg et al., 1996).”
BackgroundInfluentialRegulation of cyclin E transcription by E2Fs and retinoblastoma protein.
Geng, Y., Eaton, E. N., Picón, M., Roberts, J. M., Lundberg, A. S., Gifford, A. M., Sardet, C., & Weinberg, R. A. (1996) · PubMed · Cited by 378
Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L., & Jacks, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80274-9 · Cited by 372 · cited 1×
“Consistent with these in vitro studies, apoptosis in Rb-deficient mice is mediated in certain tissues by an E2F1–p53-Apaf-1–dependent pathway (Morgenbesser et al., 1994; Macleod et al., 1996; Tsai et al., 1998; Guo et al., 2001).”
BackgroundSellers, W. R., Novitch, B. G., Miyake, S., Heith, A., Otterson, G. A., Kaye, F. J., Lassar, A. B., & Kaelin, W. G. (1998) · Genes & Development · doi:10.1101/gad.12.1.95 · Cited by 343 · cited 8×
“…examples, demonstrating a required role for Rb in terminal differentiation of certain cell types and transcriptional activation by MyoD (Gu et al., 1993; Sellers et al., 1998; Puri et al., 2001), C/EBP (Doppler et al., 1995), the glucocorticoid receptor (Stocklin et al., 1996), and other factors.”
BackgroundMethodInfluentialMacleod, K. F., Hu, Y., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01006.x · Cited by 321 · cited 1×
“Consistent with these in vitro studies, apoptosis in Rb-deficient mice is mediated in certain tissues by an E2F1–p53-Apaf-1–dependent pathway (Morgenbesser et al., 1994; Macleod et al., 1996; Tsai et al., 1998; Guo et al., 2001).”
BackgroundLigand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305 · cited 1×
“For example, cyclin D1 binds and stimulates the estrogen receptor by acting as a bridging factor between the ER and steroid receptor coactivators (Neuman et al., 1997; Zwijsen et al., 1997, 1998).”
BackgroundZacksenhaus, E., Jiang, Z., Chung, D., Marth, J. D., Phillips, R. A., & Gallie, B. L. (1996) · Genes & Development · doi:10.1101/gad.10.23.3051 · Cited by 302 · cited 6×
“A role for Rb as a survival factor is evident from the massive cell death observed in Rb-deficient mice in tissues where Rb is normally highly expressed (Lee et al., 1994; Zacksenhaus et al., 1996b; Jiang et al., 1997; Macleod, 1999).”
BackgroundMethodInfluentialSelf-citationAlmasan, A., Yin, Y., Kelly, R. E., Lee, E. Y., Bradley, A., Li, W., Bertino, J. R., & Wahl, G. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5436 · Cited by 296 · cited 2×
“Furthermore, in vitro, loss of Rb increases cell susceptibility to cytotoxic drugs, whereas ectopic expression of Rb inhibits cell death (Almasan et al., 1995; Haas-Kogan et al., 1995; Kranenburg et al., 1996).”
BackgroundInfluentialRobinson, G. W., McKnight, R. A., Smith, G. H., & Hennighausen, L. (1995) · Development · doi:10.1242/dev.121.7.2079 · Cited by 291
Molecular targets for breast cancer therapy and prevention
Bange, J., Zwick, E., & Ullrich, A. (2001) · Nature Medicine · doi:10.1038/87872 · Cited by 288 · cited 4×
“Moreover, several Cdk4/6 inhibitors that target the Rb pathway are currently in preclinical and clinical development (Bange et al., 2001).”
BackgroundInfluentialDual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation.
Lee, E. Y., Hu, N., Yuan, S. S., Cox, L. A., Bradley, A., Lee, W. H., & Herrup, K. (1994) · Genes & Development · doi:10.1101/gad.8.17.2008 · Cited by 285 · cited 3×
“…exhibit incomplete differentiation in certain tissues and aberrant expression of specific markers, for example, NGF receptors during neurogenesis (Lee et al., 1994), muscle creatine kinase during myogenesis (Zacksenhaus et al., 1996b), and filensin/crystallin B during lens development (Liu and…”
BackgroundInfluentialLukas, C., Sørensen, C. S., Kramer, E., Santoni-Rugiu, E., Lindeneg, C., Peters, J.-M., Bartek, J., & Lukas, J. (1999) · Nature · doi:10.1038/44611 · Cited by 284 · cited 1×
“Rb can modulate the progression through S and G2 (Karantza et al., 1993; Knudsen et al., 1998; Lukas et al., 1999; Knudsen et al., 2000), and unscheduled activation of Rb may interfere with DNA synthesis and/or DNA repair processes.”
BackgroundInhibition of apoptosis by the retinoblastoma gene product.
Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. K., & Israel, M. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07022.x · Cited by 281 · cited 2×
“Furthermore, in vitro, loss of Rb increases cell susceptibility to cytotoxic drugs, whereas ectopic expression of Rb inhibits cell death (Almasan et al., 1995; Haas-Kogan et al., 1995; Kranenburg et al., 1996).”
BackgroundInfluentialCyclin-dependent kinases as a therapeutic target for stroke
Osuga, H., Osuga, S., Wang, F., Fetni, R., Hogan, M. J., Slack, R. S., Hakim, A. M., Ikeda, J.-E., & Park, D. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170144197 · Cited by 281 · cited 1×
“Although such drugs have beneficial inhibitory effect on tumor growth, they have also been documented to suppress apoptosis through Rb (Osuga et al., 2000).”
BackgroundHutchinson, J., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2203-2212.2001 · Cited by 280 · cited 7×
“Recent analysis of anchorage-independent epithelial cell survival in vitro has indicated that the Rb– E2F1 complex regulates PKB/AKT activity via IGF-1 and suppresses rather than induces cell survival (Yu et al., 2001a).”
BackgroundInfluentialThink globally, act locally: the making of a mouse mammary gland
Hennighausen, L., & Robinson, G. W. (1998) · Genes & Development · doi:10.1101/gad.12.4.449 · Cited by 271 · cited 2×
“MMTV-Rb K transgenes suppress ductal growth in pubescent females During the ductal stage, the mammary epithelium infiltrates the fat pad by proliferation at the terminal endbuds (TEBs) and dichotomous side branching (Medina, 1996; Hennighausen and Robinson, 1998; Cardiff et al., 2000; Silberstein, 2001).”
BackgroundPierce, D. F., Johnson, M. D., Matsui, Y., Robinson, S. D., Gold, L. I., Purchio, A. F., Daniel, C. W., Hogan, B. L., & Moses, H. L. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2308 · Cited by 264 · cited 3×
“We note that numerous other MMTV transgenic mice expressing dominant-active alleles have been created, for example, neu/erbB2 (Siegel et al., 1999), -catenin (Imbert et al., 2001), TGF (Pierce et al., 1993), and PKB/AKT (Hutchinson et al., 2001).”
BackgroundPrecocious Mammary Gland Development in P-Cadherin–deficient Mice
Radice, G. L., Ferreira-Cornwell, M. C., Robinson, S. D., Rayburn, H., Chodosh, L. A., Takeichi, M., & Hynes, R. O. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.4.1025 · Cited by 261 · cited 3×
“…156, Number 1, 2002 gland has also been described in transgenic mice overexpressing activated -catenine (Imbert et al., 2001), stromolysin (Sympson et al., 1994), dominant negative TGF R (Gorska et al., 1998), E-cadherin (Delmas et al., 1999), and in mice lacking P-cadherin (Radice et al., 1997).”
BackgroundHamel, P. A., Gill, R. M., Phillips, R. A., & Gallie, B. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3431 · Cited by 235 · cited 10×
“Pathology analysis was performed by Dr. Colin McKerlie (Sunnybrook Hospital, Toronto, Canada).”
BackgroundMethodInfluentialClass I Histone Deacetylases Sequentially Interact with MyoD and pRb during Skeletal Myogenesis
Puri, P. L., Iezzi, S., Stiegler, P., Chen, T.-T., Schiltz, R. L., Muscat, G. E. O., Giordano, A., Kedes, L., Wang, J. Y. J., & Sartorelli, V. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00373-2 · Cited by 224 · cited 4×
“Alternatively, Rb may be required for the onset of terminal differentiation via direct or indirect stimulation of differentiation factors (e.g., glucocorticoid receptor, C/EBP, MyoD, etc.).”
BackgroundMethodInfluentialRB-Dependent S-Phase Response to DNA Damage
Knudsen, K. E., Booth, D., Naderi, S., Sever-Chroneos, Z., Fribourg, A. F., Hunton, I. C., Feramisco, J. R., Wang, J. Y. J., & Knudsen, E. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7751-7763.2000 · Cited by 224 · cited 1×
“Rb can modulate the progression through S and G2 (Karantza et al., 1993; Knudsen et al., 1998; Lukas et al., 1999; Knudsen et al., 2000), and unscheduled activation of Rb may interfere with DNA synthesis and/or DNA repair processes.”
BackgroundJhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Hennighausen, L., Roberts, A. B., Smith, G. H., & Merlino, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05832.x · Cited by 224 · cited 2×
“…directs linked transgenes exclusively to differentiated mammary epithelial cells during the estrous cycle and pregnancy, and WAP transgenes are expressed and exert phenotypic changes in both nulliparous and multiparous females (Jhappan et al., 1993; Sympson et al., 1994; Robinson et al., 1995).”
BackgroundVascular remodelling during the normal and malignant life cycle of the mammary gland
Djonov, V., Andres, A., & Ziemiecki, A. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010115)52:2<182::aid-jemt1004>3.0.co;2-m · Cited by 220
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression
Knudsen, E. S., Buckmaster, C., Chen, T.-T., Feramisco, J. R., & Wang, J. Y. J. (1998) · Genes & Development · doi:10.1101/gad.12.15.2278 · Cited by 210 · cited 5×
“…to their resistance to phosphorylation by Cdks, the Rb Ks outperform wild-type Rb in multiple assays and are viewed as constitutively active, underphosphorylated, native Rb (Hamel et al., 1992; Geng et al., 1996; Knudsen et al., 1998; Sellers et al., 1998; Brown et al., 1999; Harbour et al., 1999).”
BackgroundInfluentialΔn89β-Catenin Induces Precocious Development, Differentiation, and Neoplasia in Mammary Gland
Imbert, A., Eelkema, R., Jordan, S., Feiner, H., & Cowin, P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.3.555 · Cited by 199 · cited 2×
“We note that numerous other MMTV transgenic mice expressing dominant-active alleles have been created, for example, neu/erbB2 (Siegel et al., 1999), -catenin (Imbert et al., 2001), TGF (Pierce et al., 1993), and PKB/AKT (Hutchinson et al., 2001).”
BackgroundPan, H., Yin, C., Dyson, N. J., Harlow, E., Yamasaki, L., & Van Dyke, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80273-7 · Cited by 197 · cited 2×
“Of relevance here is the observation that both overexpression and inactivation of E2F1 induce cancer in mouse models presumably by disrupting different aspects (proliferation versus apoptosis, respectively) of cell physiology (Field et al., 1996; Yamasaki et al., 1996; Pan et al., 1998; Pierce et al., 1998, 1999).”
BackgroundThe mammary gland: A unique organ for the study of development and tumorigenesis
Medina, D. (1996) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/bf02096299 · Cited by 196
Chromatin remodeling and Rb activity
Harbour, J. W., & Dean, D. C. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00152-6 · Cited by 176 · cited 3×
“Active repression involves, at least in part, the recruitment by Rb of chromatin-modifying enzymes such as the histone deacetylase HDAC1 (Lai et al., 1999; Harbour and Dean, 2000a).”
BackgroundInfluentialComparison of the whey acidic protein genra of the rat and mouse
Campbell, S. M., Rosen, J. M., Hennighausen, L. G., Strech-Jurk, U., & Sippel, A. E. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.22.8685 · Cited by 169 · cited 2×
“WAP-HA-Rb p34. pUC-mWAP, containing a 6.75 kb of the mouse WAP gene (Campbell et al., 1984) cloned into a unique EcoRI, was purchased from American Type Culture Collection.”
MethodInfluentialLai, A., Lee, J. M., Yang, W.-M., DeCaprio, J. A., Kaelin, W. G., Seto, E., & Branton, P. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6632 · Cited by 168 · cited 3×
“Active repression involves, at least in part, the recruitment by Rb of chromatin-modifying enzymes such as the histone deacetylase HDAC1 (Lai et al., 1999; Harbour and Dean, 2000a).”
BackgroundInfluentialRetinoblastoma: the disease, gene and protein provide critical leads to understand cancer
DiCiommo, D. P., Gallie, B. L., & Bremner, R. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0326 · Cited by 162 · cited 3×
“Although germ-line mutations in Rb predispose individuals to retinoblastoma, somatic mutations in Rb are often associated with cancer progression (DiCiommo et al., 2000).”
BackgroundInfluentialJäger, R., Herzer, U., Schenkel, J., & Weiher, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201353 · Cited by 159 · cited 1×
“We note that transgenic expression of the survival factor Bcl2 in the mammary gland is not sufficient to induce mammary adenocarcinoma, although it accelerates tumorigenicity in double transgenic mice expressing Bcl2 and Myc (Jager et al., 1997).”
BackgroundE2F1 Has Both Oncogenic and Tumor-Suppressive Properties in a Transgenic Model
Pierce, A. M., Schneider-Broussard, R., Gimenez-Conti, I. B., Russell, J. L., Conti, C. J., & Johnson, D. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6408 · Cited by 151 · cited 2×
“…is the observation that both overexpression and inactivation of E2F1 induce cancer in mouse models presumably by disrupting different aspects (proliferation versus apoptosis, respectively) of cell physiology (Field et al., 1996; Yamasaki et al., 1996; Pan et al., 1998; Pierce et al., 1998, 1999).”
BackgroundThe retinoblastoma gene family is differentially expressed during embryogenesis
Jiang, Z., Zacksenhaus, E., Gallie, B. L., & Phillips, R. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201014 · Cited by 136 · cited 2×
“In situ hybridization and TUNEL were performed exactly as described (Jiang et al., 1997, 2000).”
BackgroundMethodSelf-citationDeregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development
Pierce, A. M., FISHER, S. M., Conti, C. J., & Johnson, D. G. (1998) · Oncogene · doi:10.1038/sj.onc.1201666 · Cited by 136 · cited 2×
“…is the observation that both overexpression and inactivation of E2F1 induce cancer in mouse models presumably by disrupting different aspects (proliferation versus apoptosis, respectively) of cell physiology (Field et al., 1996; Yamasaki et al., 1996; Pan et al., 1998; Pierce et al., 1998, 1999).”
BackgroundCumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity
Brown, V. D., Phillips, R. A., & Gallie, B. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3246 · Cited by 116 · cited 4×
“…been used in diverse transcriptional and cellular contexts in vitro and in vivo and invariably demonstrated the same albeit superior functions as native unphosphorylated Rb (Hamel et al., 1992; Geng et al., 1996; Knudsen et al., 1998; Sellers et al., 1998; Brown et al., 1999; Harbour et al., 1999).”
BackgroundInfluentialGorska, A. E., Joseph, H., Derynck, R., Moses, H. L., & Serra, R. A. (1998) · PubMed · Cited by 115
Side-branching in the mammary gland: the progesterone–Wnt connection
Robinson, G. W., Hennighausen, L. G., & Johnson, P. F. (2000) · Genes & Development · doi:10.1101/gad.14.8.889 · Cited by 102 · cited 1×
“K transgenes induce alveolar outgrowth and precocious differentiation in nulliparous females After puberty, the mammary epithelium undergoes cyclic proliferation, limited differentiation, and cell death during the estrous cycle (Robinson et al., 1995, 2000).”
BackgroundPeripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice
Linette, G. P., Hess, J. L., Sentman, C., & Korsmeyer, S. J. (1995) · Blood · doi:10.1182/blood.v86.4.1255.bloodjournal8641255 · Cited by 97 · cited 1×
“In contrast, expression of BCl2 in the T cell lineage induces peripheral T cell lymphoma (Linette et al., 1995).”
BackgroundZacksenhaus, E., Bremner, R., Phillips, R. A., & Gallie, B. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4588 · Cited by 94
Self-citationDoppler, W., Welte, T., & Philipp, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17962 · Cited by 91 · cited 3×
“Alternatively, Rb may be required for the onset of terminal differentiation via direct or indirect stimulation of differentiation factors (e.g., glucocorticoid receptor, C/EBP, MyoD, etc.).”
BackgroundIncreased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice
Yao, Y., Slosberg, E. D., Wang, L., Hibshoosh, H. H., Zhang, Y., Xing, W.-Q., Santella, R. M., & Weinstein, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202908 · Cited by 80 · cited 1×
“Protein lysates from mammary gland tissues were prepared as described (Yao et al., 1999).”
MethodpRb and E2f-1 in mouse development and tumorigenesis
Macleod, K. F. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80005-7 · Cited by 78 · cited 4×
“A role for Rb as a survival factor is evident from the massive cell death observed in Rb-deficient mice in tissues where Rb is normally highly expressed (Lee et al., 1994; Zacksenhaus et al., 1996b; Jiang et al., 1997; Macleod, 1999).”
BackgroundInfluentialGuo, Z., Yikang, S., Yoshida, H., Mak, T. W., & Zacksenhaus, E. (2001) · PubMed · Cited by 55
Self-citationDelmas, V., Pla, P., Feracci, H., Thiery, J. P., Kemler, R., & Larue, L. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9517 · Cited by 50 · cited 3×
“…156, Number 1, 2002 gland has also been described in transgenic mice overexpressing activated -catenine (Imbert et al., 2001), stromolysin (Sympson et al., 1994), dominant negative TGF R (Gorska et al., 1998), E-cadherin (Delmas et al., 1999), and in mice lacking P-cadherin (Radice et al., 1997).”
BackgroundLiu, Y., & Zacksenhaus, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203996 · Cited by 47 · cited 2×
“…differentiation in certain tissues and aberrant expression of specific markers, for example, NGF receptors during neurogenesis (Lee et al., 1994), muscle creatine kinase during myogenesis (Zacksenhaus et al., 1996b), and filensin/crystallin B during lens development (Liu and Zacksenhaus, 2000).”
BackgroundInfluentialSelf-citationOverproduction of Rb protein after the G1/S boundary causes G2 arrest.
Karantza, V, Maroo, A., Fay, D., & Sedivy, J. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.6640 · Cited by 44 · cited 1×
“Rb can modulate the progression through S and G2 (Karantza et al., 1993; Knudsen et al., 1998; Lukas et al., 1999; Knudsen et al., 2000), and unscheduled activation of Rb may interfere with DNA synthesis and/or DNA repair processes.”
BackgroundTranscriptional Repression by Rb-E2F and Regulation of Anchorage-Independent Survival
Yu, J. T., Foster, R. G., & Dean, D. C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3325-3335.2001 · Cited by 43 · cited 2×
“In contrast to the MMTV/WAP-Rb K transgenic mice, cyclin D1–deficient mice do not succumb to mammary tumors but are rather protected from a subset of oncogenic pathways in the mammary gland (Sicinski et al., 1995; Yu et al., 2001b).”
BackgroundResultPhosphatidylinositol 3′ Kinase Signaling in Mammary Tumorigenesis
Scheid, M. P., & Woodgett, J. R. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009520616247 · Cited by 41 · cited 1×
“These observations establish a link between Rb, E2F1, and PKB/AKT, and conceivably this same pathway may be used by Rb K to prolong cell survival via PKB in the mammary epithelium (Scheid and Woodgett, 2001).”
BackgroundJiang, Z., Liang, P., Leng, R. P., Guo, Z., Liu, Y., Liu, X., Bubnic, S., Keating, A., Murray, D., Goss, P. E., et al. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9892 · Cited by 35 · cited 1×
“In situ hybridization and TUNEL were performed exactly as described (Jiang et al., 1997, 2000).”
MethodSelf-citationDual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus, E., Jiang, Z., Phillips, R. A., & Gallie, B. L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00978.x · Cited by 32 · cited 5×
“A role for Rb as a survival factor is evident from the massive cell death observed in Rb-deficient mice in tissues where Rb is normally highly expressed (Lee et al., 1994; Zacksenhaus et al., 1996b; Jiang et al., 1997; Macleod, 1999).”
BackgroundMethodInfluentialSelf-citationKaetzel, C. S., & Ray, D. B. (1984) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(84)81267-9 · Cited by 31 · cited 1×
“The -casein monoclonal antibodies were a gift from Dr. Charlotte Kaetzel (University of Kentucky, Lexington, KY) (Kaetzel and Ray, 1984).”
MethodThe retinoblastoma protein and the cell cycle.
Sopta, M., Gallie, B. L., Rm, G., Hamel, P. A., Muncaster, M., Zacksenhaus, E., & Phillips, R. A. (1992) · PubMed · Cited by 22
Self-citation
Research works printed but not linked: 10
- 1993, Oncogene., 8, 2127
- 1996, Oncogene., 12, 1173
- 1998, Cell Growth Differ., 9, 229
- 2001, Cancer Res., 61, 8395
- 1992, Mol. Cell. Biol., 12, 3431
- 1993, Mol. Cell. Biol., 13, 6640
- 2001, Genes Dev., 15, 1833
- 2000, Cancer Res., 60, 3689
- 2001, Microsc. Res. Tech., 52, 155, 10.1002/1097-0029(20010115)52:2<155::aid-jemt1001>3.0.co;2-p · DOI · Paper page
- 1993, Mol. Cell. Biol., 13, 4588
Cited by
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
“Strikingly, these transgenic mice develop focal hyperplastic lesions and mammary tumours, probably because the survival of differentiated mammary epithelial cells is extended after pregnanc”
BackgroundThe retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
“Along these same lines, mice that express a 'hyperactive' Rb molecule (a mutated form of Rb that cannot be inactivated by phosphorylation) from the mouse mammary tumour virus (MMTV) promoter show reduced proliferation at the end buds, as well as precocious cellular differentiation and extended survival of the mammary…”
BackgroundCoordinated regulation of life and death by RB
Chau, B. N., & Wang, J. Y. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc993 · Cited by 292
“One-third of these mice developed hyperplastic nodules, and ∼7% of these mice developed adenocarcinoma”
BackgroundChinnam, M., & Goodrich, D. W. (2011) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00005-x · Cited by 199
“Consistent with this, constitutive activation of pRb in the mouse mammary gland initiates tumorigenesis (Jiang and Zacksenhaus, 2002).”
BackgroundThe retinoblastoma tumor-suppressor gene, the exception that proves the rule
Goodrich, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209616 · Cited by 164
“This functional property predicts that pRb expression may be oncogenic, a prediction that has actually been verified under certain experimental conditions (Yamamoto et al., 1999; Jiang and Zacksenhaus, 2002; Borges et al., 2005).”
Background
Metadata
- Authors
- Jiang, Z., & Zacksenhaus, E.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Zacksenhaus, Eldad
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2002-01-03
- Volume
- 156
- Issue
- 1
- Pages
- 185-198
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2173568
- OpenAlex
- W2114749101
- Cited by
- 55
- References
- 83
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- retinoblastoma protein, mammary gland, mammary adenocarcinoma, apoptosis, cell proliferation, E2F1, IGF-1 receptor, Akt signaling, transgenic mice, tumor suppressor activation, cancer therapy
- MeSH terms
- Adenocarcinoma, Alleles, Animals, Breast, Cell Differentiation, Cell Division, Cell Survival, Female, Hyperplasia, Mammary Tumor Virus, Mouse, Mice, Transgenic, Milk Proteins, Models, Biological, Mutation, Parity, Phosphorylation, Pregnancy, RNA, Messenger, Mammary Neoplasms, Animal, Retinoblastoma Protein, In Situ Hybridization, Gene Expression Regulation, Developmental, Transgenes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.